Sheets Smith Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-11,915
| Closed | -$1.01M | – | 328 |
|
|
2017
Q3 | $1.01M | Sell |
11,915
-127
| -1% | -$10.8K | 0.26% | 109 |
|
|
2017
Q2 | $912K | Sell |
12,042
-501
| -4% | -$37.9K | 0.24% | 116 |
|
|
2017
Q1 | $828K | Sell |
12,543
-284
| -2% | -$18.7K | 0.22% | 131 |
|
|
2016
Q4 | $813K | Sell |
12,827
-827
| -6% | -$52.4K | 0.23% | 121 |
|
|
2016
Q3 | $869K | Sell |
13,654
-571
| -4% | -$36.3K | 0.25% | 120 |
|
|
2016
Q2 | $1.06M | Buy |
+14,225
| New | +$1.06M | 0.31% | 92 |
|
|
2014
Q3 | – | Sell |
-15,043
| Closed | -$585K | – | 268 |
|
|
2014
Q2 | $585K | Buy |
15,043
+382
| +3% | +$14.9K | 0.16% | 170 |
|
|
2014
Q1 | $615K | Buy |
+14,661
| New | +$615K | 0.17% | 161 |
|